Argenx
ARGX
#571
Rank
$36.23 B
Marketcap
$605.92
Share price
1.54%
Change (1 day)
23.15%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $0.53 Billion USD

According to Argenx 's latest financial reports the company's total liabilities are $0.53 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.32 B1.43%
2021-12-31$0.31 B-57.55%
2020-12-31$0.74 B54.64%
2019-12-31$0.48 B818.38%
2018-12-31$52.42 M40.21%
2017-12-31$37.39 M-20.27%
2016-12-31$46.9 M351.81%
2015-12-31$10.38 M-16.71%
2014-12-31$12.46 M97.59%
2013-12-31$6.3 M-24.04%
2012-12-31$8.3 M58.18%
2011-12-31$5.24 M94.54%
2010-12-31$2.69 M